Log in
Enquire now
‌

US Patent 8986697 Antibodies for the treatment of

Patent 8986697 was granted and assigned to Progenics Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Progenics Pharmaceuticals
Progenics Pharmaceuticals
0
Date Filed
April 15, 2011
0
Date of Patent
March 24, 2015
0
Patent Application Number
13641315
0
Patent Citations Received
‌
US Patent 11891435 Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
0
Patent Inventor Names
Andre J. Marozsan
0
Shankar Kumar
0
William C. Olson
0
Yun Kang
0
Albert Cupo
0
Brian Kennedy
0
Dangshe Ma
0
Gerald P. Donovan
0
Kirsten Nagashima
0
Naoya Tsurushita
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8986697
0
Patent Primary Examiner
‌
Brian J Gangle
0

Find more entities like US Patent 8986697 Antibodies for the treatment of

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.